Veeva Systems (NYSE: VEEV) announced that its Data Quality System has aggregated and cleaned clinical trial data for more than 1 million subjects. The platform, known as Veeva DQS, has handled data across more than 1,000 studies and generated more than 500,000 automated queries. Veeva said this automation has saved sites and sponsors thousands of hours in data reconciliation.
Upcoming DQS innovations include automated data exchange with Veeva CTMS for risk-based monitoring and AI-assisted classification of study data. The recently announced Veeva Study Builder Agent configures Veeva EDC and DQS directly from a study protocol.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.